Prostate Cancer Clinical Trials in Raleigh, NC

Prostate Cancer Clinical Trials in Raleigh, NC

View the best 10 prostate cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Prostate Cancer clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for prostate cancer in Raleigh, North Carolina

Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

Salvage Radiotherapy

Radiation

Recruiting1 awardPhase 2
This trial is testing whether radiation therapy and a stronger form of hormone therapy can improve survival for men with aggressive prostate cancer that has come back after surgery.
Image of The Stamford Hospital in Stamford, United States.

Relugolix

Gonadotropin-Releasing Hormone (GnRH) Antagonist

Verified
Recruiting1 award
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Image of NCT02531516 in Homewood, United States.

Apalutamide +3 More

Androgen Receptor Inhibitor

Recruiting1 awardPhase 3
This trial tests whether combining apalutamide with another treatment helps men with high-risk prostate cancer undergoing radiation therapy. The treatment aims to block and reduce male hormones that fuel cancer growth, potentially preventing the cancer from spreading. Apalutamide has been developed for treating prostate cancer and has shown effectiveness.
Image of East Northport Medical Care in E. Northport, United States.

Talk to Nathan About Prostate Cancer Screening

Behavioral Intervention

Recruiting1 award2 criteria
This trial aims to see if an online tool called "Talk to Nathan About Prostate Cancer Screening" is helpful in assisting patients with deciding about prostate cancer screening. The trial will compare the effectiveness of this
Image of Call for Information (Investigational Site 0005) in Los Angeles, United States.

Carboplatin +7 More

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial tests pembrolizumab combined with other drugs in patients with advanced prostate cancer that doesn't respond to usual treatments. The treatment works by boosting the immune system to better attack cancer cells. Pembrolizumab has been previously tested in combination with chemotherapy for other cancers, showing improved response rates and progression-free survival.
Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Apalutamide +1 More

Antiandrogen

Recruiting1 awardPhase 3
This trial is testing if using apalutamide and hormone therapy around the time of surgery can help men with high-risk prostate cancer by reducing the hormones that help the cancer grow.
Image of Research Site in La Jolla, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the efficacy of capivasertib+abiraterone+androgen deprivation therapy to placebo+abiraterone+androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC) whose tumours are PTEN-deficient. The primary endpoint is radiographic progression-free survival.
Image of Sarah Cannon Research Institute in Denver, United States.

ST101

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial tests a new drug, ST101, given to patients with advanced cancers who haven't responded to other treatments. The study aims to find the safest and most effective dose. It includes patients with specific types of breast cancer, melanoma, brain cancer, and prostate cancer.
Image of Mayo Clinic Hospital in Phoenix, United States.

Multiparametric Magnetic Resonance Imaging

Diagnostic Test

Recruiting1 award1 criteria
This trial looks at how well MRI works in finding and staging prostate cancer, which may help treatment planning.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Walnuts

Recruiting1 awardPhase 2
This trial is testing whether walnuts can help slow the progression of prostate cancer in men who are scheduled for surgery.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.